Home > News > Biophan Technologies Files 8-K Providing NASA Conference Call Transcript
August 24th, 2004
Biophan Technologies Files 8-K Providing NASA Conference Call Transcript
Biophan Technologies, Inc. announced today that it has filed an 8-K with the Securities and Exchange Commission providing a transcript of the Company's investor conference call on Thursday, August 19, during which Biophan CEO Michael Weiner detailed to investors and other interested parties information on the Biophan / NASA's Ames Research Center agreement calling for characterization and joint development of high-density, nano-engineered thermoelectric materials for use with implantable medical devices.
Carbon Nanotubes Market by Type (SWCNTS & MWCNTS), Application (Electronics, Chemicals, Energy, Medical, Composites, Aerospace & more) & Geography - Global Trends & Forecasts To 2018 March 9th, 2014
Toxicity of Commonly-Used Nanoparticles on Human Body Studied in Iran March 9th, 2014
Aptasensors Help Detection of Cancer Protein Marker March 9th, 2014
Nano Labs Shareholder Update March 8th, 2014